These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 8278899)

  • 1. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra.
    Engberg G; Kling-Petersen T; Nissbrandt H
    Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.
    Erhardt S; Mathé JM; Chergui K; Engberg G; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):173-80. PubMed ID: 11882912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.
    Engberg G; Nissbrandt H
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):491-7. PubMed ID: 8114948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of firing rate and changes in the firing pattern of nigral dopamine neurons by gamma-hydroxybutyric acid (GHBA) are specifically induced by activation of GABA(B) receptors.
    Erhardt S; Andersson B; Nissbrandt H; Engberg G
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):611-9. PubMed ID: 9686936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excitation of nigral dopamine neurons by the GABA(A) receptor agonist muscimol is mediated via release of glutamate.
    Erhardt S; Engberg G
    Life Sci; 2000 Sep; 67(15):1901-11. PubMed ID: 11043612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of nigral dopamine neurons by the selective GABA(B)-receptor antagonist SCH 50911.
    Erhardt S; Nissbrandt H; Engberg G
    J Neural Transm (Vienna); 1999; 106(5-6):383-94. PubMed ID: 10443545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Responses of rat substantia nigra dopamine-containing neurones to (-)-HA-966 in vitro.
    Grobaski KC; Ping H; daSilva HM; Bowery NG; Connelly ST; Shepard PD
    Br J Pharmacol; 1997 Feb; 120(4):575-80. PubMed ID: 9051293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of dopamine re-uptake: significance for nigral dopamine neuron activity.
    Engberg G; Elverfors A; Jonason J; Nissbrandt H
    Synapse; 1997 Feb; 25(2):215-26. PubMed ID: 9021902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABAergic control of rat substantia nigra dopaminergic neurons: role of globus pallidus and substantia nigra pars reticulata.
    Celada P; Paladini CA; Tepper JM
    Neuroscience; 1999 Mar; 89(3):813-25. PubMed ID: 10199615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of excitatory amino acid receptor subtypes on the electrophysiological activity of dopaminergic and nondopaminergic neurons in rat substantia nigra.
    Zhang J; Chiodo LA; Freeman AS
    J Pharmacol Exp Ther; 1994 Apr; 269(1):313-21. PubMed ID: 7513359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GABAB receptors in GABA and baclofen-induced inhibition of adult rat cerebellar interpositus nucleus neurons in vitro.
    Chen K; Li HZ; Ye N; Zhang J; Wang JJ
    Brain Res Bull; 2005 Oct; 67(4):310-8. PubMed ID: 16182939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GABA(A) and GABA(B) antagonists differentially affect the firing pattern of substantia nigra dopaminergic neurons in vivo.
    Paladini CA; Tepper JM
    Synapse; 1999 Jun; 32(3):165-76. PubMed ID: 10340627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons.
    Obrietan K; van den Pol AN
    J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GABA(B) modulation of dopamine release in the nucleus accumbens core.
    Pitman KA; Puil E; Borgland SL
    Eur J Neurosci; 2014 Nov; 40(10):3472-80. PubMed ID: 25229321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presynaptic GABAB and adenosine A1 receptors regulate synaptic transmission to rat substantia nigra reticulata neurones.
    Shen KZ; Johnson SW
    J Physiol; 1997 Nov; 505 ( Pt 1)(Pt 1):153-63. PubMed ID: 9409479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol.
    Xu D; Karain B; Brantley E; Shi WX
    J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression of glutamatergic and GABAergic synaptic responses in striatal spiny neurons by stimulation of presynaptic GABAB receptors.
    Nisenbaum ES; Berger TW; Grace AA
    Synapse; 1993 Jul; 14(3):221-42. PubMed ID: 8105549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity.
    Smith ID; Grace AA
    Synapse; 1992 Dec; 12(4):287-303. PubMed ID: 1465742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologically induced cessation of burst activity in nigral dopamine neurons: significance for the terminal dopamine efflux.
    Nissbrandt H; Elverfors A; Engberg G
    Synapse; 1994 Aug; 17(4):217-24. PubMed ID: 7992197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons.
    Arborelius L; Chergui K; Murase S; Nomikos GG; Höök BB; Chouvet G; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Apr; 347(4):353-62. PubMed ID: 8510763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.